Life Science Success

Send us Fan Mail

This week on Life Science Success Podcast my guest is Yan Leyfman, MD is a unique individual in life sciences and is someone we all need to be paying attention to. Yan was raised in the medically deprived community that was ravaged by the Chernobyl nuclear disaster. Today, we are going to talk about his experience with Chernobyl, how that led to his career in medicine and what he has done to turn struggles into triumphs.

Send us Fan Mail

Lee is a results-focused operations executive in biotech and medical devices with deep experience in leveraging lean six sigma methodologies to drive cost-saving initiatives and improve operational efficiency in an organization. He has a great ability to motivate, encourage, and develop high-performing teams helping individuals take their performance to the next level.

Send us Fan Mail

This week on the Life Science Success podcast my guest is Tom Denison. His passion is mentoring, advising, and funding biotech startups. He has engaged with over 200+ startups, at all stages, from concept to exit.

Tom is the Founder and Chief Relationship Officer of SmartHealth Catalyzer, the hub for Midwest Biotech Venture Creation.

Send us Fan Mail

We discuss her journey from passionate Scientist to an inventor to entrepreneur. In her newest venture, she is helping new science become transformative therapeutics. Elaine is a cutting-edge Life Science leader helping companies become a reality from Oaklahoma.

Send us Fan Mail

In this interview, I speak with Laura Prisc the Most Trusted Authority on Conscious Leadership for High-Performance Organizations. For more than 20 years, she's worked side-by-side with leaders at all levels in organizations of every size imaginable, from one-location operations through the full continuum of multi-site global organizations.

Send us Fan Mail

This week on the podcast I interview Jacob Glanville, PhD we discuss Jacob's journey that led him to Distributed Bio then to Centivax and his work on the Netflix show Pandemic. Jacob Glanville is a serial entrepreneur and computational immuno-engineer. He built and sold his first company Distributed Bio from founding in March of 2012 to a 104M dollar sale to Charles River Laboratories in December of 2020. During that period, he developed the core business model, the research teams, and the technologies that enabled Distributed Bio to become profitable without investment. As part of the acquisition agreement, he founded Centivax Inc and spun out his assets in COVID-19 therapeutics, broad-spectrum vaccines, antivenom antibodies, anti-wound pathogen antibodies, anti-CXCR5 autoimmunity therapeutics, and blood-brain barrier translation technologies into Centivax, where he is now CEO.

Send us Fan Mail

This week's guest is Dave Bjork the Research Evangelist. He is a Patient Advocate, Lung Cancer Survivor, Speaker and Advisor. His career spans more than 20 years of progressive experience in nonprofit marketing, patient advocacy and fundraising leadership roles including Vice President of Development, National Foundation for Cancer Research, Bethesda, MD. In this role, He launched several fundraising and advocacy programs and became known as the “Cancer Research Evangelist” because of his dedication and commitment to basic scientific research. He also hosts the Research Evangelist Podcast.  

Send us Fan Mail

In this interview, I have the tremendous opportunity to speak with Preveen Ramamoorthy PhD of Regenerative Medical Solutions. We talk about his journey from India to Clemson and the work that he is currently doing with Regenerative Medical Solutions. His current work on Type I and Type II diabetes and his work at the University of Colorado Denver. 

Send us Fan Mail

In this episode, I interview Debora Barton, MD, and we discuss Carisma Therapeutics (CAR-T, CAR-M, Macrophage, and Cancer Therapies) as well as her new board role at Tigerlily Foundation.

Send us Fan Mail

In this week's podcast, I interview Neil Sankar and we talk about his work in helping teams bring cancer therapies to market. He has worked at the National Cancer Institute and for the past 20 years has been working with large and small pharmaceutical companies that are trying to bring drugs to market. His experience spans small molecules, biologics, and antibody-drug conjugates used in the treatment of advanced tumors. Our conversation covers elements of his 20-year career, leaders he would most like to have a conversation with, and what led him to his career in oncology.